Editorial Note: We earn a commission from partner links on Forbes Advisor. Commissions do not affect our editors’ opinions or evaluations. The rate on a 30-year fixed refinance rose to 7.06% today, according to the Mortgage Research Center. The 15-year, fixed-rate refinance mortgage average rate is 6.03%. For 20-year mortgage refinances, the average rate is … Read more
Editorial Note: We earn a commission from partner links on Forbes Advisor. Commissions do not affect our editors’ opinions or evaluations. The rate on a 30-year fixed refinance rose to 6.96% today, according to the Mortgage Research Center. For 15-year fixed refinance mortgages, the average rate is 5.91%, and for 20-year mortgages, the average is … Read more
Editorial Note: We earn a commission from partner links on Forbes Advisor. Commissions do not affect our editors’ opinions or evaluations. The rate on a 30-year fixed refinance rose to 6.78% today, according to the Mortgage Research Center. The average rate on a 15-year mortgage refinance is 5.64%. On a 20-year mortgage refinance, the average … Read more
In celebration of Women’s History Month, Brown, Goldstein & Levy celebrates the vital role of women throughout history. We are proud of BGL’s managing partner, Jessie Weber, and all our women attorneys who go above and beyond to bring the highest quality legal services to clients in Maryland, DC, and across the country. From our … Read more
By David Bautz, PhD NASDAQ:EDSA READ THE FULL EDSA RESEARCH REPORT Business Update Advancing EB06 for Treating Vitiligo Edesa Biotech, Inc. (NASDAQ:EDSA) is planning for a Phase 2 study of its anti-CXCL10 monoclonal antibody for the treatment of moderate-to-severe non-segmental vitiligo patients. Vitiligo is a disease that causes areas of the skin to lose color, … Read more